Employees: 11-50
Total raised: $50M
Founded date: 2020
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.04.2022 | Series A | $50M | - |
Mentions in press and media 4
| Date | Title | Description |
| 26.07.2024 | Leading innovation: 10 promising European startups focusing on biopharmaceuticals | Biopharmaceuticals, often known as bio-pharma, represent a dynamic sector within the pharmaceutical industry that uses biological processes to develop drugs and therapies. Unlike traditional pharmaceuticals, which are typically synthesized ... |
| 18.04.2022 | Cimeio Therapeutics Raises $50M in Series A Funding | Cimeio Therapeutics, a Basel, Switzerland- and Boston, MA-based biotechnology company developing a novel approach to cell therapies, raised $50m in Series A funding. The round was led by Versant Ventures. Led by CEO Thomas Fuchs, Cimeio The... |
| 14.04.2022 | Cimeio Therapeutics secures $50M Series A | Cimeio Therapeutics has raised a $50 million round from Versant Ventures. The company is a developer of cell-shielding technology and immunotherapies that are designed to treat rare genetic diseases, hematologic malignancies and autoimmune ... |
| 13.04.2022 | Newly launched biotech banks CHF46 million |